Grifols SA ADR (GRFS)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ
Market Cap: $5.91B
Last updated: Nov 17, 2026 at 11:05 AM ET
Grifols SA ADR (GRFS) Competitors
The companies most similar to Grifols SA ADR are Organon (OGN), GSK (GSK) and Biogen (BIIB). Grifols SA ADR trades at 9.9x earnings, against a median of 21.4x for the 7 of these companies with a P/E. By market cap, Grifols SA ADR ranks 9th of the 12 companies on this page; Gilead Sciences (GILD) is the largest at $208.48B.
Peer Comparison
GRFS's ROIC of 7.6% is above the peer median of 5.2%, and its revenue growth of 9.4% is above the median of 6.8%. It yields 1.08%, while the median peer pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Grifols SA ADR (GRFS) | $5.91B | 9.9x | 0.7x | 6.4% | 7.6% | 9.4% | 1.08% |
| Organon & Co (OGN) | $3.65B | 4.6x | 0.6x | 3.5% | 6.2% | -1.7% | 0.58% |
| GSK plc (GSK) | $101.13B | 10.5x | 2.3x | 13.0% | N/A | 4.0% | 3.58% |
| Biogen Inc (BIIB) | $37.46B | 21.4x | 3.6x | 3.4% | 1.3% | 10.6% | 0.00% |
| GRAIL, LLC (GRAL) | $5.21B | N/A | 29.6x | -243.8% | N/A | 3.7% | 0.00% |
| Sanofi ADR (SNY) | $116.15B | N/A | 2.0x | 8.2% | 7.6% | 15.7% | 5.01% |
| Bristol-Myers Squibb Company (BMY) | $129.66B | 10.1x | 2.6x | 18.5% | 13.9% | 6.9% | 4.00% |
| Gilead Sciences Inc (GILD) | $208.48B | N/A | 6.7x | -12.5% | -3.9% | 6.8% | 1.96% |
| Bio-Rad Laboratories Inc (BIO) | $9.85B | 37.3x | 3.7x | 39.5% | 4.1% | 0.5% | 0.00% |
| TG Therapeutics Inc (TGTX) | $9.75B | 87.2x | 11.1x | 11.8% | 11.0% | 60.7% | 0.00% |
| Kodiak Sciences Inc (KOD) | $7.27B | N/A | N/A | 0.0% | -1481.8% | 0.0% | 0.00% |
| CareDx Inc (CDNA) | $4.09B | 48.2x | 6.4x | 25.9% | N/A | 39.3% | 0.00% |
| Peer median | $9.85B | 21.4x | 3.7x | 8.2% | 5.2% | 6.8% | 0.00% |
Similar Companies
These are the 11 companies most similar to Grifols SA ADR, ranked by how closely their business, size, sector and industry match. The largest group, 6 of the 11, is in Drug Manufacturers - General; the other 5 span 3 industries.
| Company | About | Peers |
|---|---|---|
| Organon & Co (OGN)Drug Manufacturers - General | Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. | OGN competitors |
| GSK plc (GSK)Drug Manufacturers - General | GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines... | GSK competitors |
| Biogen Inc (BIIB)Drug Manufacturers - General | Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development... | BIIB competitors |
| GRAIL, LLC (GRAL)Diagnostics & Research | GRAIL, LLC is a leading biotechnology firm specializing in advanced cancer diagnostics... | GRAL competitors |
| Sanofi ADR (SNY)Drug Manufacturers - General | Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe... | SNY competitors |
| Bristol-Myers Squibb Company (BMY)Drug Manufacturers - General | Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. | BMY competitors |
| Gilead Sciences Inc (GILD)Drug Manufacturers - General | Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California... | GILD competitors |
| Bio-Rad Laboratories Inc (BIO)Medical Devices | Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical... | BIO competitors |
| TG Therapeutics Inc (TGTX)Biotechnology | TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development... | TGTX competitors |
| Kodiak Sciences Inc (KOD)Biotechnology | Kodiak Sciences Inc., a clinical-stage biopharmaceutical company, is dedicated to researching, developing... | KOD competitors |
| CareDx Inc (CDNA)Diagnostics & Research | CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. | CDNA competitors |
Frequently Asked Questions About GRFS
Who are Grifols SA ADR's main competitors?
The companies most similar to Grifols SA ADR include Organon (OGN), GSK (GSK), Biogen (BIIB), GRAIL, LLC (GRAL) and Sanofi ADR (SNY), listed from the closest match.
Who is Grifols SA ADR's biggest competitor?
Gilead Sciences (GILD) is the largest of the similar companies at $208.48B; Organon (OGN) is the closest match by business profile, size, sector and industry.
How does GRFS stock compare with its competitors?
GRFS' P/E is 9.9x against a peer median of 21.4x; its P/S is 0.7x against a peer median of 3.7x; its net margin is 6.4% against a peer median of 8.2%.
Which of Grifols SA ADR's competitors pays a higher dividend?
Grifols SA ADR has a forward dividend yield of 1.08%. Sanofi ADR (SNY), Bristol-Myers Squibb Company (BMY), GSK (GSK) and Gilead Sciences (GILD) have higher forward dividend yields; Sanofi ADR (SNY) has the highest at 5.01%.
Is Grifols SA ADR bigger than its competitors?
No. Grifols SA ADR is 9th by market cap among the 12 companies on this page; the largest is Gilead Sciences (GILD) at $208.48B.
GRFS pages: Overview, Dividends, Financials, Valuation, Competitors, Government Contracts